BamSEC and AlphaSense Join Forces
Learn More

CytomX Therapeutics Inc.

NASDAQ: CTMX    
Share price (1/8/25): $0.98    
Market cap (1/8/25): $76.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Amendment No. 1 to the Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 4 to the Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Transition Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Sent via Docusign March 13, 2021 Total Rewards: Compensation
12/34/56
EX-10.2
from 10-Q 7 pages Amended and Restated Severance and Change of Control Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 3 to the Collaboration and License Agreement Part 1 - Amendments to Certain Terms
12/34/56
EX-10.1
from 8-K 55 pages Unit Purchase Agreement
12/34/56
EX-10
from 10-Q 16 pages 2. Premises: A
12/34/56
EX-10
from 10-K 65 pages Collaboration and License Agreement by and Between CytomX Therapeutics, Inc. and Modernatx, Inc. Dated as of December 30, 2022
12/34/56
EX-10
from 10-K 67 pages Collaboration and License Agreement by and Between CytomX Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc. Dated as of November 16, 2022
12/34/56
EX-10.6
from 10-Q 8 pages Amendment No 3 to Collaboration and License Agreement
12/34/56
EX-10.5
from 10-Q 8 pages September 30, 2022 Alison Hannah, M.D. [***] Re: Employment Separation Dear Alison
12/34/56
EX-10.4
from 10-Q 8 pages September 12, 2022 Amy C. Peterson, M.D. [***] Re: Employment Separation Dear Amy
12/34/56
EX-10.3
from 10-Q 8 pages September 30 Carlos Campoy [***] Re: Employment Separation Dear Carlos
12/34/56
EX-10.2
from 10-Q 11 pages Master Consulting Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Master Consulting Agreement
12/34/56
EX-10.20
from 10-K 14 pages Amendment No. 2 to the Collaboration and License Agreement Part 1 - Amendments to Certain Terms
12/34/56
EX-10.3
from 10-K 9 pages CytomX Therapeutics, Inc. 2015 Equity Incentive Plan Restricted Share Unit Award Grant Notice
12/34/56
EX-10.3
from 10-Q 5 pages Business Consulting Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Amendment No 2 to Collaboration and License Agreement
12/34/56